Improved anti-serum albumin binding variants

Details for Australian Patent Application No. 2010215482 (hide)

Owner Glaxo Group Limited

Inventors De Angelis, Elena; Enever, Carolyn; Liu, Haiqun; Plummer, Christopher; Schon, Oliver

Agent Davies Collison Cave

Pub. Number AU-A-2010215482

PCT Pub. Number WO2010/094723

Priority 61/163,987 27.03.09 US; 61/153,746 19.02.09 US; 61/247,136 30.09.09 US

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094723 Priority application(s): WO2010/094723

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215486-Method for making lactid acid bacteria composition

2010215481-Improved anti-serum albumin binding variants